There’s been no shortage of either in recent weeks. Plunging valuations across the biotech sector were thrust into the ...
Viking Therapeutics seems to be doubling down on its hopes of making waves in the weight management market as a stand-alone ...
Biotech is an area that may offer your portfolio growth today and earnings stability tomorrow. The idea is a biotech stock ...
Cargo Therapeutics, a Bay Area biotech company, announced in a filing Tuesday that it is discontinuing its drug development ...
Offering free solutions can generate goodwill and strengthen relationships with both existing and potential customers. When a ...
The Fed kept rates unchanged for now, a move that was widely expected. It did note, though, that “uncertainty around the ...
1d
The Chosun Ilbo on MSNKorean biotech firms race into $26 billion U.S. biosimilar marketSouth Korean biotech firms are targeting the $26 billion biosimilar market opening up as patents expire on more than 10 ...
One of the biggest hurdles in the sugar and ethanol industries is strict government regulations on wastewater management, ...
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Late last year, the chief leasing officer for Kilroy Realty Corp. saw more biotech companies showing interest in the second ...
Curevo, a Seattle-based biotech startup developing a vaccine against shingles, raised $110 million in a Series B ...
Curetopia, a Biotech DAO, leverages decentralized science to accelerate rare disease research Zug, Switzerland, 20th March ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results